NCT06648889 2026-01-15Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic LeukemiaGoethe UniversityPhase 2 Recruiting40 enrolled